Details for Patent: 10,596,178
✉ Email this page to a colleague
Which drugs does patent 10,596,178 protect, and when does it expire?
Patent 10,596,178 protects TABRECTA and is included in one NDA.
This patent has forty-eight patent family members in thirty countries.
Summary for Patent: 10,596,178
| Title: | Tablet formulation of 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl) imidazo [1,2-B] [1,2,4] triazin-2-yl] benzamide |
| Abstract: | The present invention is related to tablets comprising of 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,-2-b][1,2,4]triazin- -2-yl]benzamide, processes for the production thereof, and uses in the treatment of certain cancers. |
| Inventor(s): | Goncalves; Elisabete (Basel, CH), Tauchmann; Christin (Sankt Florianweg, GE), Yen; Shau-Fong (Basel, CH), Vippagunta; Sudha (Morris Plains, NJ), Zong; Zhixin (Franklin Park, NJ) |
| Assignee: | Novartis AG (Basel, CH) |
| Application Number: | 16/134,162 |
|
Patent Claim Types: see list of patent claims | Compound; Dosage form; |
Drugs Protected by US Patent 10,596,178
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis Pharm | TABRECTA | capmatinib hydrochloride | TABLET;ORAL | 213591-001 | May 6, 2020 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| Novartis Pharm | TABRECTA | capmatinib hydrochloride | TABLET;ORAL | 213591-002 | May 6, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,596,178
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 101286 | ⤷ Try a Trial | |||
| Australia | 2015293539 | ⤷ Try a Trial | |||
| Australia | 2018207947 | ⤷ Try a Trial | |||
| Australia | 2020200912 | ⤷ Try a Trial | |||
| Australia | 2021202500 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
